Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months

Autor: Russell, F.M., Balloch, A., Licciardi, P.V., Carapetis, J.R., Tikoduadua, L., Waqatakirewa, L., Cheung, Y.B., Mulholland, E.K., Tang, M.L.K.
Zdroj: In Vaccine 15 June 2011 29(27):4499-4506
Databáze: ScienceDirect